Path to Acceptance: Manuscript Submission Strategies from NEJM – Register Now

Join us for the next event in our Advancing Authorship series.

When: Tuesday, April 2, 1:00pm-2:30pm
Where: Mortimer B. Zuckerman Research Center, Room 105, 417 E 68th St, New York, NY, 10065 (entrance on 69th Street)
Register now to save your seat!

Ever wanted to get the inside scoop on what it take to publish in a top journal? Join us for an interactive session and discover tips and tricks for manuscript submission. Come listen to the following guest speakers. We have also set some time aside for attendees to ask their questions!

Dr. Edward Campion, Executive Editor at NEJM
* Dr. Mark E. Robson, Chief, Breast Medicine Service, MSK
* Dr. David Spriggs, Director of the Gynecologic Oncology Program at Massachusetts General Hospital and Associate Editor, NEJM

Accreditation Statement
Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement
Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Register now to save your seat!

Catch MSK Library at MSK’s IT Expo 2019

MSK’s annual IT Expo is taking place April 10 and April 11, 2019. Among this year’s training options for staff, the MSK Library will be offering the following two classes:

Evaluating Scholarly Journals
(Thursday, April 11 from 10:00 am to 11:00 am, RRL-102)
Instructor: Konstantina (Dina) Matsoukas

Course Description: Come to this workshop to find out about the library and information resources that can help you to more comprehensively evaluate a journal’s “quality”. A variety of criteria that should be considered when deciding on where to submit a research manuscript for publication will be discussed.

Learning Objectives – To learn how to evaluate a journal by considering such criteria as:
• Journal metrics (impact factors, rankings, etc)
• Indexing & abstracting services
• Open-access vs traditional publishing models
• Peer-review systems
• Copyright & permissions for re-use
• Digital archiving for posterity
• Journal policies & requirements

ORCID: Open Research and Contributor ID (New class!)
(Thursday, October 30 from 3:00 pm to 4:00 pm, RRL-102)
Instructor: Konstantina (Dina) Matsoukas and Jeanine McSweeney

Course Description: As more and more publishers require that authors include an ORCID iD during the publication submission process, you might be wondering – what is ORCID, anyway? In this class, attendees will learn ORCID basics (what it is and how it works) and why an ORCID ID is an important tool for all authors who want to distinguish their work from others, maximize their research impact, and maintain compliance with publishers and granting agencies. Attendees will also learn about the connection between ORCID iD and Synapse, MSK’s publications and author profile system.

Learning Objectives – Learners will be able to:
• Define what ORCID iD is and describe why it exists
• Identify how author name disambiguation impacts researchers
• Understand how to sign up for an ORCID iD and the benefits of the ORCID@MSK service
• Understand how MSK’s publications and author profile system (Synapse) can be leveraged to populate ORCID profiles

We hope to see you there! If your schedule does not permit, however, be sure to check out other MSK Library training options available year-round.

Young Patients Often Face Misdiagnoses When it Comes to Colon Cancer

Many younger patients see more than one doctor and face misdiagnoses before being given a diagnosis of colorectal cancer (CRC), according to recent research presented during a webcast ahead of the 2019 AACR Annual Meeting.

Researchers reviewed 1195 online surveys completed by individuals who were diagnosed with CRC before the age of 50 and found that 57% were diagnosed between the ages of 40 and 49; 33% were diagnosed between 30 and 39; and only 10% were diagnosed before the age of 30. Thirty percent had a family history of CRC and 8% were diagnosed with Lynch syndrome, which can be a genetic predisposition to the disease.

The majority of these younger patients (70%) were diagnosed with stage III or stage IV disease – a contrast to their older counterparts, who are more likely to be diagnosed at stage I or II disease, according to the researchers.

The researchers attribute this difference to lack of awareness and misdiagnosis, as over 60% of these patients waited over a year to see a doctor, and 67% of these patients saw at least two doctors before their diagnosis.

March is Colorectal Cancer Awareness Month. Learn more about how MSKCC is fighting colon cancer. The Infographic on this post is courtesy of the National Cancer Institute.